Responses to Cytokine Inhibitors Associated with Cellular Composition in Models of Immune‐Mediated Inflammatory Arthritis
Objective Immune‐mediated inflammatory arthritis (IMIA) is a heterogeneous group of diseases including rheumatoid arthritis (RA), psoriatic arthritis (PsA), and spondyloarthritis (SpA). Disease‐modifying antirheumatic drugs (DMARDs) target very different cellular components of the disease processes....
Main Authors: | Morten A. Nielsen, Søren Lomholt, Anders Mellemkjær, Morten N. Andersen, Christopher D. Buckley, Tue W. Kragstrup |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2020-01-01
|
Series: | ACR Open Rheumatology |
Online Access: | https://doi.org/10.1002/acr2.11094 |
Similar Items
-
Resveratrol displays anti-inflammatory properties in an ex vivo model of immune mediated inflammatory arthritis
by: S. Lomholt, et al.
Published: (2018-10-01) -
IL-12/IL-23p40 identified as a downstream target of apremilast in models of arthritis
by: Tue W. Kragstrup, et al.
Published: (2019-02-01) -
The IL-20 Cytokine Family in Rheumatoid Arthritis and Spondyloarthritis
by: Tue W. Kragstrup, et al.
Published: (2018-09-01) -
The antifibrotic drug pirfenidone inhibits spondyloarthritis fibroblast-like synoviocytes and osteoblasts in vitro
by: Julie Stougaard, et al.
Published: (2018-11-01) -
The anti-inflammatory cytokine interleukin-37 is an inhibitor of trained immunity
by: Giulio Cavalli, et al.
Published: (2021-04-01)